IN saline 0.9% — Competitive Intelligence Brief

IN saline 0.9% (IN saline 0.9%) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution / Fluid replacement. Area: Critical Care / Supportive Care.

phase 3 Electrolyte solution / Fluid replacement Critical Care / Supportive Care Small molecule

Target snapshot

IN saline 0.9% (IN saline 0.9%) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Normal saline (0.9% sodium chloride solution) is an isotonic fluid that maintains cellular hydration and electrolyte balance when administered intravenously.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
IN saline 0.9% TARGET	IN saline 0.9%	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	phase 3	Electrolyte solution / Fluid replacement
saline infusion	saline infusion	University Hospital, Linkoeping	marketed	Electrolyte solution / Fluid replacement
Saline solution ("B")	Saline solution ("B")	Hospital Universitari de Bellvitge	marketed	Electrolyte solution / Fluid replacement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution / Fluid replacement class)

1. Hospital Universitari de Bellvitge · 1 drug in this class
2. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
3. University Hospital, Linkoeping · 1 drug in this class